These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18197130)

  • 1. Efficacy of a portable, audible-only electromyography device in the treatment of spasmodic dysphonia.
    Jeffcoat BT; Schweinfurth JM
    Laryngoscope; 2008 May; 118(5):942-3. PubMed ID: 18197130
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
    Casserly P; Timon C
    J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of current practices of physicians who treat adductor spasmodic dysphonia in the U.S.
    Chang CY; Chabot P; Walz CM
    Ear Nose Throat J; 2009 May; 88(5):E18. PubMed ID: 19444777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia.
    Chang CY; Chabot P; Thomas JP
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):894-9. PubMed ID: 17547976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpharmacologic effects of botulinum toxin on the life quality of patients with spasmodic dysphonia.
    Anari S; Carding PN; Hawthorne MR; Deakin J; Drinnan MJ
    Laryngoscope; 2007 Oct; 117(10):1888-92. PubMed ID: 17690610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-centre retrospective review of unilateral and bilateral Dysport injections in adductor spasmodic dysphonia.
    Elmiyeh B; Prasad VM; Upile T; Saunders N; Youl BD; Epstein R; Rubin JS
    Logoped Phoniatr Vocol; 2010 Apr; 35(1):39-44. PubMed ID: 20350075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review).
    Yin S; Stucker FJ; Nathan CO
    J La State Med Soc; 2001 Feb; 153(2):92-7. PubMed ID: 11261363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.
    Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND
    Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voice handicap index results for older patients with adductor spasmodic dysphonia.
    Wingate JM; Ruddy BH; Lundy DS; Lehman J; Casiano R; Collins SP; Woodson GE; Sapienza C
    J Voice; 2005 Mar; 19(1):124-31. PubMed ID: 15766857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin therapy for abductor spasmodic dysphonia.
    Woodson G; Hochstetler H; Murry T
    J Voice; 2006 Mar; 20(1):137-43. PubMed ID: 16126369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND; Wodchis WP; Spak C; Kileny PR
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A. An alternative treatment for migraine.
    Moses LL
    Adv Nurse Pract; 2009 Dec; 17(12):40-1. PubMed ID: 20014704
    [No Abstract]   [Full Text] [Related]  

  • 13. Lower facial contouring with botulinum toxin type A.
    Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
    J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of essential palatal myoclonus in a 10-year-old girl with botulinum neurotoxin.
    Krause E; Leunig A; Klopstock T; Gürkov R
    Otol Neurotol; 2006 Aug; 27(5):672-5. PubMed ID: 16868515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum toxin A in the treatment of concomitant strabismus in children].
    Oleszczyńska-Prost E
    Klin Oczna; 2004; 106(1-2):64-7. PubMed ID: 15218768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of tension-type headache with botox: a review of the literature.
    Rozen D; Sharma J
    Mt Sinai J Med; 2006 Jan; 73(1):493-8. PubMed ID: 16470328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptual analyses of spasmodic dysphonia before and after treatment.
    Cannito MP; Woodson GE; Murry T; Bender B
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spasmodic dysphonia in an adolescent patient with an autoimmune neurologic disorder.
    Boseley ME; Gherson S; Hartnick CJ
    Am J Otolaryngol; 2007; 28(2):140-2. PubMed ID: 17362824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
    Song PC; Schwartz J; Blitzer A
    Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.